NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Epiphron Capital

Epiphron Capital

Beijingepiphroncapital.com

Overview

Epiphron Capital is an international equity investment firm focused on the biotechnology and life sciences sectors.

Year Founded

2016

Portfolio Companies

3

Investments

Epiphron Capital investments
CompanyDateStageLead
LakeShore Biopharma Co., Ltd.Nov 2025M&ACo-investor
ClarapathNov 2021Series BCo-investor
InmageneJun 2021Series CCo-investor
LakeShore Biopharma Co., Ltd.Feb 2021Series BCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBeijing
Year Founded2016

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.